UNLABELLED: Objectives In the US, Black men who have sex with men (BMSM) are disproportionately affected by HIV/AIDS. Pre-exposure prophylaxis (PrEP) holds tremendous promise for curbing the HIV/AIDS epidemic among these men. However, many psychosocial components must be addressed in order to implement this prevention tool effectively among BMSM. METHODS: We assessed PrEP knowledge and use, health care access experiences, race-based medical mistrust, sexual partners and behaviours, and drug and alcohol use among 699 men attending a community event in the south-eastern United States. We used generalised linear modelling to assess factors associated with their willingness to use PrEP. RESULTS: Three hundred and ninety-eight men reported being BMSM and having HIV-negative status. Among these men, 60% reported being willing to use PrEP. Lack of being comfortable with talking to a health care provider about having sex with men, not having discussed having sex with a man with a health care provider, race-based medical mistrust, and alcohol consumption and substance use were all identified as barriers to willingness to use PrEP. Sexual risk-taking, number of sex partners and STI diagnosis were not associated with willingness to use PrEP. CONCLUSIONS: Findings from the current paper demonstrate the importance of acknowledging the role of various psychosocial factors in the uptake of PrEP. It is imperative that we prioritise research into understanding these barriers better, as the failure to do so will impede the tremendous potential of this prevention technology.
UNLABELLED: Objectives In the US, Black men who have sex with men (BMSM) are disproportionately affected by HIV/AIDS. Pre-exposure prophylaxis (PrEP) holds tremendous promise for curbing the HIV/AIDS epidemic among these men. However, many psychosocial components must be addressed in order to implement this prevention tool effectively among BMSM. METHODS: We assessed PrEP knowledge and use, health care access experiences, race-based medical mistrust, sexual partners and behaviours, and drug and alcohol use among 699 men attending a community event in the south-eastern United States. We used generalised linear modelling to assess factors associated with their willingness to use PrEP. RESULTS: Three hundred and ninety-eight men reported being BMSM and having HIV-negative status. Among these men, 60% reported being willing to use PrEP. Lack of being comfortable with talking to a health care provider about having sex with men, not having discussed having sex with a man with a health care provider, race-based medical mistrust, and alcohol consumption and substance use were all identified as barriers to willingness to use PrEP. Sexual risk-taking, number of sex partners and STI diagnosis were not associated with willingness to use PrEP. CONCLUSIONS: Findings from the current paper demonstrate the importance of acknowledging the role of various psychosocial factors in the uptake of PrEP. It is imperative that we prioritise research into understanding these barriers better, as the failure to do so will impede the tremendous potential of this prevention technology.
Authors: Gordon Mansergh; Beryl A Koblin; Grant N Colfax; David J McKirnan; Stephen A Flores; Sharon M Hudson Journal: J Acquir Immune Defic Syndr Date: 2010-10 Impact factor: 3.731
Authors: Rachel C Shelton; Gary Winkel; Stacy N Davis; Nicole Roberts; Heiddis Valdimarsdottir; Simon J Hall; Hayley S Thompson Journal: J Gen Intern Med Date: 2010-03-02 Impact factor: 5.128
Authors: Sarit A Golub; Kristi E Gamarel; H Jonathon Rendina; Anthony Surace; Corina L Lelutiu-Weinberger Journal: AIDS Patient Care STDS Date: 2013-04 Impact factor: 5.078
Authors: Patrick S Sullivan; Osamah Hamouda; Valerie Delpech; Jennifer E Geduld; Joseph Prejean; Caroline Semaille; John Kaldor; Cinta Folch; Eline Op de Coul; Ulrich Marcus; Gwenda Hughes; Chris P Archibald; Francoise Cazein; Ann McDonald; Jordi Casabona; Ard van Sighem; Kevin A Fenton Journal: Ann Epidemiol Date: 2009-06 Impact factor: 3.797
Authors: Charlotte-Paige Rolle; Eli S Rosenberg; Nicole Luisi; Jeremy Grey; Travis Sanchez; Carlos Del Rio; John L Peterson; Paula M Frew; Patrick S Sullivan; Colleen F Kelley Journal: Int J STD AIDS Date: 2016-10-20 Impact factor: 1.359
Authors: Sarah J Marks; Roland C Merchant; Melissa A Clark; Tao Liu; Joshua G Rosenberger; Jose Bauermeister; Kenneth H Mayer Journal: AIDS Patient Care STDS Date: 2017-11 Impact factor: 5.078
Authors: Kristen Underhill; Kathleen M Morrow; Christopher Colleran; Richard Holcomb; Sarah K Calabrese; Don Operario; Omar Galárraga; Kenneth H Mayer Journal: J Urban Health Date: 2015-08 Impact factor: 3.671
Authors: Steven A John; H Jonathon Rendina; Tyrel J Starks; Christian Grov; Jeffrey T Parsons Journal: AIDS Patient Care STDS Date: 2019-01-17 Impact factor: 5.078
Authors: Ronald A Brooks; Raphael J Landovitz; Rotrease Regan; Sung-Jae Lee; Vincent C Allen Journal: Int J STD AIDS Date: 2015-01-30 Impact factor: 1.359
Authors: Benjamin B Strauss; George J Greene; Gregory Phillips; Ramona Bhatia; Krystal Madkins; Jeffrey T Parsons; Brian Mustanski Journal: AIDS Behav Date: 2017-05
Authors: Sarah M Peitzmeier; Catherine Tomko; Erin Wingo; Anne Sawyer; Susan G Sherman; Nancy Glass; Chris Beyrer; Michele R Decker Journal: AIDS Care Date: 2017-03-08
Authors: Lisa A Eaton; Derrick D Matthews; Leigh A Bukowski; M Ruvel Friedman; Cristian J Chandler; Darren L Whitfield; Jordan M Sang; Ron D Stall Journal: J Acquir Immune Defic Syndr Date: 2018-11-01 Impact factor: 3.731